You are here

  • Home
  • Online First
  • Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis: a validation study

Article info

Article menu

Download PDFPDF

Correspondence
Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis: a validation study
Free

Authors

  1. Correspondence to Elise van Mulligen, Rheumatology, Erasmus MC, Rotterdam 3000 CA, The Netherlands; elise.vanmulligen{at}erasmusmc.nl
View Full Text

Citation

van Mulligen E, van der Helm-van Mil A, de Jong PHP
Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis: a validation study
Annals of the Rheumatic Diseases Published Online First: 13 January 2021. doi: 10.1136/annrheumdis-2020-219499

Publication history

  • Received November 13, 2020
  • Accepted November 16, 2020
  • First published January 13, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.